154 related articles for article (PubMed ID: 22116676)
1. Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.
Oh G; Lau KK
Int Urol Nephrol; 2012 Oct; 44(5):1467-72. PubMed ID: 22116676
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
[TBL] [Abstract][Full Text] [Related]
3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
4. [Hemolytic uremic syndrome: the experience of a pediatric center].
Cavagnaro F; Gana JC; Lagomarsino E; Vogel A; Gederlini A
Rev Med Chil; 2005 Jul; 133(7):781-7. PubMed ID: 16341384
[TBL] [Abstract][Full Text] [Related]
5. Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.
Van Dyck M; Proesmans W
Pediatr Nephrol; 2004 Jun; 19(6):688-90. PubMed ID: 15064939
[TBL] [Abstract][Full Text] [Related]
6. Postdiarrheal hemolytic uremic syndrome in Egyptian children: An 11-year single-center experience.
Eid R; Bakr A; Elmougy A; Zedan MM; Allam NA; Sarhan A; Hammad A; El-Refaey AM; Hamdy N
Saudi J Kidney Dis Transpl; 2020; 31(6):1376-1387. PubMed ID: 33565450
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.
Ninchoji T; Nozu K; Nakanishi K; Horinouchi T; Fujimura J; Yamamura T; Minamikawa S; Ishimori S; Nakanishi K; Yoshikawa N; Morioka I; Kaito H; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):889-894. PubMed ID: 28074307
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome: defining the need for long-term follow-up.
Small G; Watson AR; Evans JH; Gallagher J
Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
[TBL] [Abstract][Full Text] [Related]
9. Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
Caletti MG; Balestracci A; Missoni M; Vezzani C
Pediatr Nephrol; 2013 May; 28(5):745-50. PubMed ID: 23250713
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
Monet-Didailler C; Godron-Dubrasquet A; Madden I; Delmas Y; Llanas B; Harambat J
Pediatr Nephrol; 2019 Apr; 34(4):657-662. PubMed ID: 30368614
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned in the management of hemolytic uremic syndrome in children.
Tapper D; Tarr P; Avner E; Brandt J; Waldhausen J
J Pediatr Surg; 1995 Feb; 30(2):158-63. PubMed ID: 7738732
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome.
Robson WL; Leung AK; Brant R
Am J Nephrol; 1993; 13(3):194-7. PubMed ID: 8213930
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].
Zambrano O P; Delucchi B A; Cavagnaro S F; Hevia J P; Rosati M MP; Lagos R E; Nazal Ch V; González C C; Barrera B P; Alvarez L E; Pinto S V; Salas del C P; Cano Sch F; Contreras M A; Galanti de la P M; Gana A JC; Zamorano C J; Espinoza B A; Dreves R P; Pereira M J; Bidegain S A; Pasten P E; Yáñez P L; Cerda F V; Rodríguez S E; Aglony I M; Gutiérrez I E; Salas P F; Figueroa Y S; Valenzuela A M; Grandy H J; Guerra A B; Lapadula A M; Reutter de la M P; Gallardo T V; Maldonado S D; Azócar P M; Cavada Ch G
Rev Med Chil; 2008 Oct; 136(10):1240-6. PubMed ID: 19194619
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.
Garg AX; Suri RS; Barrowman N; Rehman F; Matsell D; Rosas-Arellano MP; Salvadori M; Haynes RB; Clark WF
JAMA; 2003 Sep; 290(10):1360-70. PubMed ID: 12966129
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction during long-term follow-up in children with STEC hemolytic-uremic syndrome.
Kreuzer M; Sollmann L; Ruben S; Leifheit-Nestler M; Fischer DC; Pape L; Haffner D
Pediatr Nephrol; 2017 Jun; 32(6):1005-1011. PubMed ID: 28180952
[TBL] [Abstract][Full Text] [Related]
16. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China.
Zhao SA; Ning BT; Mao JH
World J Pediatr; 2017 Apr; 13(2):183-185. PubMed ID: 28353273
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hemolytic uremic syndrome after acute stage].
Ye LY; Yu ZH; Huang ZX; Chen XM; Ren RN; Chen GM; Wang CF; Xia GZ; Huang J; Wang FJ
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):206-9. PubMed ID: 16624060
[TBL] [Abstract][Full Text] [Related]
19. [Microalbuminuria in pediatric patients diagnosed with hemolytic uremic syndrome].
Cubillos C MP; Del Salas P; Zambrano PO
Rev Chil Pediatr; 2015; 86(2):92-6. PubMed ID: 26235688
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.
Ağbaş A; Göknar N; Akıncı N; Yıldırım ZY; Taşdemir M; Benzer M; Gökçe İ; Candan C; Küçük N; Uzuner S; Özçelik G; Demirkol D; Sever L; Çalışkan S
Pediatr Nephrol; 2018 Dec; 33(12):2371-2381. PubMed ID: 30159625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
